.'indian ip and liabilities law barrier to pharma r&d investment' . april 2008 (21).yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.. she suffered a "third brain bleed" and was pronounced brain dead on monday..., and bones, and it�s not clear how the drugs will affect them after long-term use.